Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Dec 15:9:642794.
doi: 10.3389/fbioe.2021.642794. eCollection 2021.

Plant Virus Nanoparticles for Anti-cancer Therapy

Affiliations
Review

Plant Virus Nanoparticles for Anti-cancer Therapy

Srividhya Venkataraman et al. Front Bioeng Biotechnol. .

Abstract

Plant virus nanoparticles (VNPs) are inexpensive to produce, safe, biodegradable and efficacious as treatments. The applications of r plant virus nanoparticles range from epitope carriers for vaccines to agents in cancer immunotherapy. Both VNPs and virus-like particles (VLPs) are highly immunogenic and are readily phagocytosed by antigen presenting cells (APCs), which in turn elicit antigen processing and display of pathogenic epitopes on their surfaces. Since the VLPs are composed of multiple copies of their respective capsid proteins, they present repetitive multivalent scaffolds which aid in antigen presentation. Therefore, the VLPs prove to be highly suitable platforms for delivery and presentation of antigenic epitopes, resulting in induction of more robust immune response compared to those of their soluble counterparts. Since the tumor microenvironment poses the challenge of self-antigen tolerance, VLPs are preferrable platforms for delivery and display of self-antigens as well as otherwise weakly immunogenic antigens. These properties, in addition to their diminutive size, enable the VLPs to deliver vaccines to the draining lymph nodes in addition to promoting APC interactions. Furthermore, many plant viral VLPs possess inherent adjuvant properties dispensing with the requirement of additional adjuvants to stimulate immune activity. Some of the highly immunogenic VLPs elicit innate immune activity, which in turn instigate adaptive immunity in tumor micro-environments. Plant viral VLPs are nontoxic, inherently stable, and capable of being mass-produced as well as being modified with antigens and drugs, therefore providing an attractive option for eliciting anti-tumor immunity. The following review explores the use of plant viruses as epitope carrying nanoparticles and as a novel tools in cancer immunotherapy.

Keywords: cancer 2; imaging; nanoparticles; plant virus-like particles; therapeutics.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
(A) Tobacco mosaic virus structure, RNA is in red, protein subunits in blue Source: https://pdb101.rcsb.org/motm/109. (B) Cowpea mosaic virus structure, Protein subunits in red and blue Source: fineartamerica. com. (C) An overview of a portion of the PVX virus (right). The three domains of the protein are shin in yellow, green and cyan, the RNA in red. The magnification on the left displays only one single CP with a fragment of RNA.

Similar articles

Cited by

References

    1. Adams M. J., Antoniw J. F., Bar-Joseph M., Brunt A. A., Candresse T., Foster G. D., et al. (2004). Virology Division News: The New Plant Virus Family Flexiviridae and Assessment of Molecular Criteria for Species Demarcation. Arch. Virol. 149 (5), 1045–1060. 10.1007/s00705-004-0304-0 - DOI - PubMed
    1. Albakri M. M., Veliz F. A., Fiering S. N., Steinmetz N. F., Sieg S. F. (2020). Endosomal Toll‐like Receptors Play a Key Role in Activation of Primary Human Monocytes by Cowpea Mosaic Virus. Immunology 159 (2), 183–192. 10.1111/imm.13135 - DOI - PMC - PubMed
    1. Aljabali A. A. A., Shukla S., Lomonossoff G. P., Lomonossoff N. F., Steinmetz D. J. (2013). CPMV-DOX Delivers. Mol. Pharmaceutics 10 (1), 3–10. 10.1021/mp3002057 - DOI - PMC - PubMed
    1. Balke I., Zeltins A. (2020). Recent Advances in the Use of Plant Virus-like Particles as Vaccines. Viruses 12 (3), 270. 10.3390/v12030270 - DOI - PMC - PubMed
    1. Beatty P. H., Lewis J. D. (2019). Cowpea Mosaic Virus Nanoparticles for Cancer Imaging and Therapy. Adv. Drug Deliv. Rev. 145, 130–144. 10.1016/j.addr.2019.04.005 - DOI - PubMed